Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with RLMD: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
RLMD
Relmada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
RLMD
Relmada Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
DRUG
No earnings history for DRUG.
RLMD
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±12.8%
▼
−8.01%
×0.63
= implied
DRUG realized, solid
RLMD realized, hatched
One scale, both sides: full bar = 13%
× = |realized| ÷ implied
Source: market data
DRUG
Bright Minds Biosciences Inc.
Change
22.87
▲
+10.48%
· post 22.66
Mkt cap
$175.6M
RLMD
Relmada Therapeutics, Inc.
Change
3.91
▲
+3.58%
· post 3.91
Closed
Nov 6 '26
Mkt cap
$438.3M
vs
Compare
Closed
Nov 6 '26
DRUG
Bright Minds Biosciences Inc.
vs
RLMD
Relmada Therapeutics, Inc.
22.87
▲
+10.48%
post 22.66
Price
3.91
▲
+3.58%
post 3.91
$175.6M
Mkt cap
$438.3M
Change
Change
DRUG
22.87
▲
+10.48%
vs
RLMD
3.91
▲
+3.58%
Closed
Nov 6 '26